Annual Global Discovery to Development Innovation Forum Speakers
Director of Discovery Biology & Discovery Sciences
Rob has been at AstraZeneca since 2016 where he leads the Discovery Biology department part of the Innovative Medicines organisation. The group, based in Gothenburg, Sweden, supports early stage drug discovery projects providing reagents and assays with a focus on cardiovascular, metabolic and respiratory disease areas. Previously he worked at MedImmune, the biologics arm of AstraZeneca, from 2013 to 2016 where he led the Biologics Profiling team. He started his industrial career in 2001 at Vernalis, a UK biotech company focused on developing cancer therapeutics using structure-based drug design. He held various positions culminating in leading the HTS group as well as impacting on several small molecule research programmes.